Quantros acquires Comparion Medical Analytics

Quantros acquired Comparion Medical Analytics on March 1, strengthening its enterprise solutions and healthcare information services capabilities. Terms of the deal were not disclosed.

Comparion’s software helps more than 1,000 healthcare professionals from academic medical centers, health systems, Fortune 500 companies and payers assess the cost and quality of their medical services.

Quantros is a leading provider of enterprise SaaS-based solutions and services for monitoring, reporting and measuring clinical and financial performance. Quantros, which is owned by Francisco Partners, currently has more than 10,000 healthcare facilities and care settings as customers.

Comparion’s headquarters will remain in Greenville, S.C., and support for the company’s CARE Performance Assessment Suite will remain in place. Comparion founder Thane Forthman will now serve as chief analytics officer at Quantros.

“Both companies have a common mission and focus for helping customers to achieve measurable progress in the delivery of high-quality, coordinated and safer care,” Forthman said in a news release. “As a combined enterprise, we’re far better positioned to grow and support customers through the transition to value-based care and reimbursement.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.